Literature DB >> 25743224

Prevalence of autoimmune disease in moyamoya disease patients in Western Chinese population.

Jian-Bin Chen1, Yi Liu2, Liang-Xue Zhou1, Hong Sun1, Min He1, Chao You3.   

Abstract

The pathogenesis of moyamoya remains to be elucidated and an immunologic basis has been suggested. For gaining further insight into the pathogenesis of moyamoya, we explored the epidemiological characteristics of autoimmune disease in moyamoya disease (MMD) in Western Chinese population. Retrospective clinical characteristic analysis of patients with angiographically confirmed MMD was performed and compared with the general Chinese population. A significantly higher prevalence of autoimmune disease was observed, particularly type 1 diabetes mellitus (P<0.001, 7.0% vs 1.2%, χ(2) test) and Graves disease (P<0.001, 7.0% vs 0.34%, χ(2) test) in the general Chinese population. The overall prevalence of autoimmune disease in MMD was up to 31.0% (44/142). This study suggested higher overall prevalence of autoimmune disease in MMD in Western China when compared with the general Chinese population. The findings further supported that autoimmune abnormality might associate with MMD and autoimmune component to pathogenesis of moyamoya vasculopathy.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune disease; Comorbidity; Moyamoya disease; Pathogenesis; Prevalence; Risk factor

Mesh:

Year:  2015        PMID: 25743224     DOI: 10.1016/j.jns.2015.02.037

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Moyamoya complicated by thrombotic cerebrovascular accident in a Caucasian woman with collagenous colitis.

Authors:  Manshi Valluri; Hossein Akhondi; Mark Hyndman
Journal:  Neurol Sci       Date:  2018-08-09       Impact factor: 3.307

2.  Moyamoya syndrome causing stroke in young women with type 1 diabetes.

Authors:  Jing W Hughes; Jennifer A Wyckoff; Abby S Hollander; Colin P Derdeyn; Janet B McGill
Journal:  J Diabetes Complications       Date:  2016-08-12       Impact factor: 2.852

Review 3.  Experimental Animal Models for Moyamoya Disease: A Species-Oriented Scoping Review.

Authors:  Lei Cao; Yang Dong; Kaiwen Sun; Dongpeng Li; Hao Wang; Hongwei Li; Bo Yang
Journal:  Front Surg       Date:  2022-07-01

Review 4.  Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases.

Authors:  Kirsten B Dorschel; John E Wanebo
Journal:  Appl Clin Genet       Date:  2021-03-18

5.  Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: A single-center study of 212 cases.

Authors:  Qinglian Li; Lai Qu; Yongjie Yuan; Baofeng Xu; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-12-15

6.  Gene dysregulation in peripheral blood of moyamoya disease and comparison with other vascular disorders.

Authors:  Xing Peng; Zhengshan Zhang; Dongqing Ye; Peiqi Xing; Zhengxing Zou; Hongxing Lei; Lian Duan
Journal:  PLoS One       Date:  2019-09-18       Impact factor: 3.240

Review 7.  Western Moyamoya Phenotype: A Scoping Review.

Authors:  Raphael Miller; Santiago R Unda; Ryan Holland; David J Altschul
Journal:  Cureus       Date:  2021-11-22

Review 8.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.